Inventor
FERNANDEZ-SALAS ESTER
US73 patents
⚠️ This page may combine multiple inventors who share the name “FERNANDEZ-SALAS ESTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
36 patentsUS7897157B2Mar 1, 2011
Activatable clostridial toxins
ALLERGAN INC62 citations99
US7749514B2Jul 6, 2010
Activatable clostridial toxins
ALLERGAN INC64 citations99
US7332567B2Feb 19, 2008
Fret protease assays for clostridial toxins
ALLERGAN INC96 citations99
US7208285B2Apr 24, 2007
Fret protease assays for botulinum serotype A/E toxins
ALLERGAN INC117 citations99
US7183066B2Feb 27, 2007
Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
ALLERGAN INC126 citations99
US7811584B2Oct 12, 2010
Multivalent clostridial toxins
ALLERGAN INC79 citations98
US7740868B2Jun 22, 2010
Activatable clostridial toxins
ALLERGAN INC63 citations98
US7495069B2Feb 24, 2009
FRET protease assays for botulinum serotype A/E toxins
ALLERGAN INC52 citations98
US7846722B2Dec 7, 2010
Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
ALLERGAN INC55 citations97
US7645570B2Jan 12, 2010
Botulinum toxin screening assays
ALLERGAN INC68 citations97
US7598027B2Oct 6, 2009
Botulinum toxin screening assays
ALLERGAN INC61 citations97
US7718766B2May 18, 2010
Fret protease assays for botulinum serotype A/E toxins
ALLERGAN INC37 citations96
US7709608B2May 4, 2010
Substrates useful for FRET protease assays for botulinum serotype A/E toxins
ALLERGAN INC37 citations96
US7678550B1Mar 16, 2010
FRET protease assays for botulinum serotype A/E toxins
ALLERGAN INC35 citations96
US7514088B2Apr 7, 2009
Multivalent Clostridial toxin derivatives and methods of their use
ALLERGAN INC106 citations96
US7223577B2May 29, 2007
Post-translational modifications and Clostridial neurotoxins
ALLERGAN INC48 citations95
US8052979B2Nov 8, 2011
Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
ALLERGAN INC30 citations93
US8021859B2Sep 20, 2011
Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
ALLERGAN INC19 citations93
US7749759B2Jul 6, 2010
Cell compositions useful for cell-based FRET assays for clostridial toxins
ALLERGAN INC39 citations93
US8841111B2Sep 23, 2014
Degradable clostridial toxins
ALLERGAN INC9 citations92
US8697414B2Apr 15, 2014
Degradable clostridial toxins
ALLERGAN INC9 citations92
US8361789B2Jan 29, 2013
Cells useful for immuno-based Botulinum toxin serotype A activity assays
ALLERGAN INC13 citations92
US7534863B2May 19, 2009
Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins
ALLERGAN INC15 citations92
US7491799B2Feb 17, 2009
Modified botulinum neurotoxins
ALLERGAN INC34 citations92
US11332518B2May 17, 2022
Immuno-based botulinum toxin serotype A activity assays
ALLERGAN INC7 citations84
US10501731B2Dec 10, 2019
Degradable clostridial toxins
ALLERGAN INC6 citations84
US8022172B2Sep 20, 2011
Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
ALLERGAN INC10 citations84
US11261240B2Mar 1, 2022
Immuno-based botulinum toxin serotype A activity assays
ALLERGAN INC7 citations83
US7691983B2Apr 6, 2010
Chimera botulinum toxin type E
ALLERGAN INC11 citations82
US10703806B2Jul 7, 2020
Immuno-based botulinum toxin serotype A activity assays
ALLERGAN INC10 citations81
US9943576B2Apr 17, 2018
Formulations of biologics for intravesical instillation
ALLERGAN INC10 citations79
US9297003B2Mar 29, 2016
Degradable Clostridial toxins
ALLERGAN INC2 citations74
US9284545B2Mar 15, 2016
Degradable clostridial toxins
ALLERGAN INC2 citations74
US8697413B2Apr 15, 2014
Degradable clostridial toxins
ALLERGAN INC2 citations74
US8685693B2Apr 1, 2014
Degradable clostridial toxins
ALLERGAN INC2 citations74
US8685692B2Apr 1, 2014
Degradable clostridial toxins
ALLERGAN INC2 citations74
STEWARD LANCE E
7 patentsUS8071110B2Dec 6, 2011
Activatable clostridial toxins
STEWARD LANCE E32 citations96
US8623999B2Jan 7, 2014
Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systems
STEWARD LANCE E27 citations92
US8273358B2Sep 25, 2012
Activatable clostridial toxins
STEWARD LANCE E11 citations92
US8128940B2Mar 6, 2012
Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
STEWARD LANCE E25 citations92
US8512992B2Aug 20, 2013
Degradable clostridial toxins
STEWARD LANCE E5 citations84
US8460682B2Jun 11, 2013
Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
STEWARD LANCE E6 citations84
US8273865B2Sep 25, 2012
Multivalent clostridial toxins
STEWARD LANCE E8 citations84
FERNANDEZ-SALAS ESTER
6 patentsUS8198034B2Jun 12, 2012
Immuno-based botulinum toxin serotype A activity assays
FERNANDEZ-SALAS ESTER63 citations96
US8124357B2Feb 28, 2012
Lipophilic dye-based fret assays for clostridal toxin activity
FERNANDEZ-SALAS ESTER36 citations92
US9249216B2Feb 2, 2016
Immuno-based botulinum toxin serotype A activity assays
FERNANDEZ-SALAS ESTER23 citations90
US8535941B2Sep 17, 2013
Lipophilic dye-based FRET assays for clostridial toxin activity
FERNANDEZ-SALAS ESTER6 citations84
US8067231B2Nov 29, 2011
Clostridial toxin activity assays
FERNANDEZ-SALAS ESTER13 citations84
US8497081B2Jul 30, 2013
Botulinum toxin screening assays
FERNANDEZ-SALAS ESTER9 citations83
WANG JOANNE
1 patentShowing the top 50 of 73 patents by PatentIndex Score.